DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 171 filers reported holding DEPOMED INC in Q4 2014. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $325,000 | -75.3% | 30,242 | -71.1% | 0.00% | -80.0% |
| Q1 2017 | $1,314,000 | -53.9% | 104,715 | -33.8% | 0.02% | -46.4% |
| Q4 2016 | $2,852,000 | +269.0% | 158,272 | +411.9% | 0.03% | +250.0% |
| Q3 2016 | $773,000 | +31.2% | 30,921 | +3.1% | 0.01% | +14.3% |
| Q2 2016 | $589,000 | +27.8% | 30,003 | -9.3% | 0.01% | 0.0% |
| Q1 2016 | $461,000 | -24.7% | 33,091 | -1.9% | 0.01% | 0.0% |
| Q4 2015 | $612,000 | +18.8% | 33,736 | +23.4% | 0.01% | 0.0% |
| Q3 2015 | $515,000 | +1156.1% | 27,340 | +1342.7% | 0.01% | +600.0% |
| Q2 2015 | $41,000 | -57.7% | 1,895 | -68.4% | 0.00% | 0.0% |
| Q4 2014 | $97,000 | -62.8% | 5,995 | -65.2% | 0.00% | -75.0% |
| Q3 2014 | $261,000 | +6.5% | 17,208 | +1.8% | 0.00% | 0.0% |
| Q1 2014 | $245,000 | +99.2% | 16,898 | -22.7% | 0.00% | +33.3% |
| Q2 2013 | $123,000 | – | 21,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 2,252,402 | $31,376,000 | 7.88% |
| Healthcare Value Capital, LLC | 350,000 | $4,876,000 | 7.16% |
| Senvest Management, LLC | 4,977,256 | $69,333,000 | 5.82% |
| Consonance Capital Management LP | 2,756,360 | $38,396,000 | 5.81% |
| Opaleye Management Inc. | 325,000 | $4,527,000 | 2.82% |
| Krensavage Asset Management, LLC | 447,000 | $6,227,000 | 2.23% |
| Healthcare Value Capital, LLC | 100,000 | $1,393,000 | 2.05% |
| Starboard Value LP | 2,950,000 | $41,094,000 | 1.44% |
| HealthInvest Partners AB | 200,000 | $2,786,000 | 1.30% |
| OAK RIDGE INVESTMENTS LLC | 7,206,286 | $100,384,000 | 1.29% |